Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...

Kidney Transplant III: Nursing Management

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.

Current opinion in cardiology·2026

Same author

Cardiovascular Health Profiles in Pregnant, Postpartum, and Nonpregnant Reproductive-Aged Women Using Life's Essential 8 Scores.

JACC. Advances·2026

Same author

The novelty of anticoagulation in LVAD Therapy: Current Practice, the Role of Direct Oral Anticoagulants, and Future Directions.

Journal of cardiovascular pharmacology·2026

Same author

Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Same author

Development of a novel risk score to predict 1-year mortality following donation after circulatory death heart transplant.

The Journal of thoracic and cardiovascular surgery·2026

Same author

The Association Between Social Determinants of Health, Race, and Sex on Risk for Readmission After Heart Transplantation.

Journal of cardiac failure·2026

Search research articles

Related Experiment Video

Updated: Jul 21, 2025

Optimization of the Cuff Technique for Murine Heart Transplantation

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

New system, old problem: Increased wait time for high-priority transplant candidates.

Erin Harris¹, Lorenzo Sewanan¹, Veli K Topkara¹

¹Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation

|July 28, 2023

Summary

This summary is machine-generated.

The 2018 heart transplant policy did not change wait times for the sickest patients (Status 1). However, wait times for Status 2 heart transplant candidates significantly increased post-policy.

Keywords:

UNOS registry heart allocation policy heart transplantation mechanical circulatory support waitlist mortality

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration

Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration

Published on: May 29, 2015

Related Experiment Videos

Last Updated: Jul 21, 2025

Optimization of the Cuff Technique for Murine Heart Transplantation

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration

Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration

Published on: May 29, 2015

Area of Science:

Cardiology
Transplant Surgery
Public Health Policy

Background:

The 2018 heart allocation policy aimed to optimize organ distribution and reduce mortality among critically ill patients awaiting transplantation.
Previous allocation systems faced challenges in effectively stratifying risk and prioritizing the sickest candidates.

Purpose of the Study:

To evaluate the impact of the 2018 heart allocation policy on wait times for adult, single-organ heart transplant recipients.
To assess changes in waitlist duration stratified by patient priority status, blood type, and geographic region.

Main Methods:

Analysis of adult single-organ heart transplant recipients from the United Network for Organ Sharing (UNOS) registry.
Data collection spanned from October 18, 2018, to July 8, 2022, divided into four post-policy implementation periods.
Comparison of median and mean wait times based on priority status (Status 1 vs. Status 2), blood type, and UNOS region.

Main Results:

No significant change in median wait times was observed for Status 1 (highest priority) patients.
A statistically significant increase of 4.2 days in mean wait time was found for Status 2 patients with each subsequent period post-policy.
Wait times were longest for blood type O and shortest for blood types AB and A, with regional variations persisting and increasing over time.

Conclusions:

The 2018 heart allocation policy did not improve wait times for the highest acuity patients (Status 1).
The policy was associated with a progressive increase in wait times for Status 2 heart transplant candidates.
Blood type O and regional factors continue to influence heart transplant wait times, necessitating further policy refinement.